For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after ...

Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.

近日,中山大学肿瘤医院泌尿外科韩辉教授团队在Cancer Cell(影响因子48.8)发表了题为Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based ...

The European Commission (“EC”) granted marketing approval to AbbVie’s Rinvoq for treating giant cell arteritis (“GCA”), an ...

During a live event, Matthew Galsky, MD discussed neoadjuvant and adjuvant options for a patient case including nivolumab or ...

New research reveals that chemotherapy can lead to rapid and widespread changes in brain connectivity in breast cancer patients.

New research published in the Journal of Magnetic Resonance Imaging has uncovered changes in brain connectivity during chemotherapy in patients with breast cancer.

New research published in the Journal of Magnetic Resonance Imaging has uncovered changes in brain connectivity during ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab)-based perioperative regimen has been approved by the European ...

The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus chemotherapy for treating resectable ...

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...